SpectraScience Inc. announced that it has received regulatory approval for the WavSTAT4 Optical Biopsy System in Saudi Arabia. This approval will result in the delivery of a Marketing Authorization license, which is the first step in selling the technology to hospitals and physicians in the Kingdom of Saudi Arabia.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.97K | |
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B |
- Stock Market
- Equities
- SCIE Stock
- News SpectraScience, Inc.
- SpectraScience Announces SFDA Approval in Saudi Arabia for WavSTAT4